On October 9, 2019, President Trump issued an executive order on agency reliance on informal guidance documents. The order seeks to curb what the Administration believes to be a “back-door” practice of regulation that allows agencies to improperly bypass the […]
On October 9, 2019, the Trump administration released two proposed rules seeking to revamp current fraud and abuse regulations to support the transition to value-based payment. The first would amend regulations implementing the anti-kickback statute and civil monetary penalty law […]
On October 4, 2019, President Trump issued a proclamation requiring immigrants seeking entry into the U.S. to prove that they will obtain health insurance within 30 days of entering the United States or have the resources to pay for “reasonably […]
On October 3, 2019, President Trump issued an executive order requiring the Medicare program to implement more market-based policies—some which were included in his October 2017 executive order—and support the Medicare Advantage program. Specifically, the order calls for (1) reducing […]
On June 24, 2019, President Trump issued an executive order on price and quality transparency, requiring the Department of Health and Human Services and the Secretary of the Treasure to issue a variety of proposed regulations and guidance within 60 […]
On September 22, 2018, the Trump administration issued a proposed rule that would newly consider an immigrant’s use of Medicaid, SNAP, Medicare Part D Low-Income Subsidy program and several housing programs to determine whether an individual is a “public charge” for […]
On May 11, 2018, President Trump and HHS Secretary Alex Azar introduced their “American Patients First” initiative, described as a blueprint to lower drug prices and reduce out-of-pocket costs for patients. The plan also included a request for information (RFI) […]
The President’s FY 2019 budget includes several widely-reported health care proposals, such as an additional attempt at repealing and replacing the Affordable Care Act, as well as efforts to reduce the cost of prescription drugs and combat the opioid epidemic. […]
On January 30, 2017, President Trump signed an Executive Order requiring agencies proposing any new regulation to identify at least two existing regulations for repeal. The Executive Order also directs agency heads that any new incremental costs associated with a […]
On January 20, 2017, the Trump administration issued a regulatory review memorandum, instructing agency heads to freeze new and pending regulations for review by the new administration. More specifically, the memorandum directs agency heads to: Send no regulations to the […]
Attorney advertising. Prior results do not guarantee a similar outcome.
300 New Jersey Avenue NW, Suite 900 Washington, DC 20001
For Inquiries Please Contact:
Tim Kuhn, Director of Operations
(202) 567-6201
© Eyman Associates / Website by because you're busy.
